COVID-19: Epidemiological Update for the Hauts-de-France Region as of September 9, 2021

Key Points

  • Slowdown in regional epidemic activity in week 35, with a decrease in positivity and testing rates, but viral circulation remains high among 10- to 29-year-olds and in densely populated areas of the region;

  • A slowdown in the health impact on healthcare provision, notably with a decrease in new hospitalizations and new admissions to critical care units observed in week 35;

  • As of September 7, nearly 4 out of 5 residents of Hauts-de-France (73.0%) had received at least one dose of the COVID-19 vaccine, and more than two-thirds (68.3%) had completed their vaccination series, though subregional disparities persist.

In relation to

Our latest news

news

Etienne Pot Appointed Interim Director General of Santé publique France

news

Arboviral Diseases in 2026: Mosquito-Borne Diseases Continue to Spread This...

news

Andes Hantavirus: Implementation of epidemiological investigations and...